<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04611997</url>
  </required_header>
  <id_info>
    <org_study_id>FUGES-020</org_study_id>
    <nct_id>NCT04611997</nct_id>
  </id_info>
  <brief_title>IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy</brief_title>
  <official_title>Clinical Outcomes of Indocyanine Green Tracer Using in Laparoscopic Gastrectomy With Lymph Node Dissection for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fujian Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fujian Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with locally advanced gastric adenocarcinoma (cT2-4a N-/+ M0) were selected as study&#xD;
      subjects to investigate the safety, efficacy, and feasibility of ICG near-infrared imaging&#xD;
      tracing in guiding laparoscopic D2 lymph node dissection for gastric cancer after neoadjuvant&#xD;
      chemotherapy by comparing injection ICG group and non-injection ICG group&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2023</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Group A (Study Group): Laparoscopic gastrectomy group with the use of near-infrared imaging (ICG group) Group B (Control Group): Laparoscopic gastrectomy group without the use of near-infrared imaging (Non-ICG group)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>3-year disease free survival rate</measure>
    <time_frame>3 years</time_frame>
    <description>Disease-free survival is calculated from the day of surgery to the day of recurrence (When the specific date of recurrence of the tumor is unknown, the ending point is the date of death due to tumor causes). In the event that neither death nor recurrence of the tumor are observed, the end point is the final date that a patient is confirmed as relapse-free.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total number of retrieved lymph nodes</measure>
    <time_frame>30 days</time_frame>
    <description>Total number of retrieved lymph nodes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Gastric Cancer</condition>
  <condition>Lymph Node Metastases</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laparoscopic gastrectomy group with the use of near-infrared imaging (ICG group)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Laparoscopic gastrectomy group without the use of near-infrared imaging (Non-ICG group)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Indocyanine Green Tracer Using in Laparoscopic Gastrectomy</intervention_name>
    <description>Indocyanine Green Tracer Using in Laparoscopic Gastrectomy with Lymph Node Dissection for Locally Advanced Gastric Cancer After Neoadjuvant</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age from 18 to 75 years&#xD;
&#xD;
          2. Primary gastric adenocarcinoma (papillary, tubular, mucinous, signet ring cell, or&#xD;
             poorly differentiated) confirmed pathologically by endoscopic biopsy&#xD;
&#xD;
          3. cT2-4a, N-/+, M0 at preoperative evaluation according to the AJCC Cancer Staging&#xD;
             Manual, 8th Edition&#xD;
&#xD;
          4. No distant metastasis, no invasion of pancreas, spleen or other adjacent organs in the&#xD;
             preoperative examinations&#xD;
&#xD;
          5. Performance status of 0 or 1 on the ECOG (Eastern Cooperative Oncology Group) scale&#xD;
&#xD;
          6. ASA (American Society of Anesthesiology) score I to III&#xD;
&#xD;
          7. Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Women during pregnancy or breast-feeding&#xD;
&#xD;
          2. Severe mental disorder&#xD;
&#xD;
          3. History of previous upper abdominal surgery (except for laparoscopic cholecystectomy)&#xD;
&#xD;
          4. History of previous gastric surgery (including ESD/EMR for gastric cancer)&#xD;
&#xD;
          5. Enlarged or bulky regional lymph node (diameter over 3cm) supported by preoperative&#xD;
             imaging.&#xD;
&#xD;
          6. Other malignant disease within the past 5 years&#xD;
&#xD;
          7. History of previous neoadjuvant chemotherapy or radiotherapy&#xD;
&#xD;
          8. History of unstable angina or myocardial infarction within past six months&#xD;
&#xD;
          9. History of cerebrovascular accident within past six months&#xD;
&#xD;
         10. History of continuous systematic administration of corticosteroids within one month&#xD;
&#xD;
         11. Requirement for simultaneous surgery for other disease&#xD;
&#xD;
         12. Emergency surgery due to complication (bleeding, obstruction or perforation) caused by&#xD;
             gastric cancer&#xD;
&#xD;
         13. FEV1 (forced expiratory volume in one second)&lt;50% of predicted values&#xD;
&#xD;
         14. Diffuse invasive gastric cancer&#xD;
&#xD;
         15. Preoperatively, tumors involving the squamocolumnar junction or duodenum were&#xD;
             confirmed&#xD;
&#xD;
         16. A history of iodine allergy&#xD;
&#xD;
         17. Refuse laparoscopic surgery&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 30, 2020</study_first_submitted>
  <study_first_submitted_qc>October 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2020</study_first_posted>
  <last_update_submitted>October 30, 2020</last_update_submitted>
  <last_update_submitted_qc>October 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fujian Medical University</investigator_affiliation>
    <investigator_full_name>Chang-Ming Huang, Prof.</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Lymphatic Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

